Related Practice Life Sciences & Pharma The COVID-19 Disease Progression Monitor delivers evidence on the effects of the disease on services, systems and therapies across the Life Sciences and Healthcare sectors 01262022170159
Executive Insights Life Sciences & Pharma Redefining Biopharma R&D Productivity: New Insights and Strategies January 9, 2025
Published Articles Business Services What do leaders get wrong when making high-risk decisions? October 10, 2024
Published Articles Sustainability To Meet Decarbonization Targets, Master The Circular Economy July 9, 2024
Podcast Life Sciences & Pharma Scope 3 Emissions: A Strategic Imperative for Pharma Companies May 8, 2024
Article Mental and Behavioral Health Exploring the Psychedelics Landscape: Looking Ahead to Funding in 2024 February 20, 2024